|Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma|
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of clinical oncology 25 (5), 571-578, 2007
|Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group|
SF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...
Journal of clinical oncology 32 (27), 3048, 2014
|Delivering affordable cancer care in high-income countries|
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
|Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer …|
D Rischin, RJ Hicks, R Fisher, D Binns, J Corry, S Porceddu, LJ Peters
Journal of Clinical Oncology 24 (13), 2098-2104, 2006
|Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non–small-cell …|
MP Mac Manus, RJ Hicks, JP Matthews, A McKenzie, D Rischin, ...
Journal of Clinical Oncology 21 (7), 1285-1292, 2003
|Evaluation of circulating tumor cells and circulating tumor DNA in non–small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab …|
EA Punnoose, S Atwal, W Liu, R Raja, BM Fine, BGM Hughes, RJ Hicks, ...
Clinical Cancer Research 18 (8), 2391-2401, 2012
|[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study|
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
|High rate of detection of unsuspected distant metastases by PET in apparent Stage III non–small-cell lung cancer: implications for radical radiation therapy|
MP Mac Manus, RJ Hicks, JP Matthews, A Hogg, AF McKenzie, A Wirth, ...
International Journal of Radiation Oncology* Biology* Physics 50 (2), 287-293, 2001
|MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome|
RP Carne, TJ O'brien, CJ Kilpatrick, LR MacGregor, RJ Hicks, MA Murphy, ...
Brain 127 (10), 2276-2285, 2004
|90Y-edotreotide for metastatic carcinoid refractory to octreotide|
DL Bushnell Jr, TM O'Dorisio, MS O'Dorisio, Y Menda, RJ Hicks, ...
Journal of Clinical Oncology 28 (10), 1652, 2010
|Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study|
V Kalff, RJ Hicks, M P. MacManus, DS Binns, AF McKenzie, RE Ware, ...
Journal of clinical oncology 19 (1), 111-118, 2001
|18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer|
RJ Hicks, V Kalff, MP MacManus, RE Ware, A Hogg, AF McKenzie, ...
Journal of Nuclear Medicine 42 (11), 1596-1604, 2001
|Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer|
SV Porceddu, E Jarmolowski, RJ Hicks, R Ware, LA Weih, D Rischin, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2005
|F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high …|
MP Mac Manus, RJ Hicks, DL Ball, V Kalff, JP Matthews, E Salminen, ...
Cancer 92 (4), 886-895, 2001
|Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation|
MS Hofman, WFE Lau, RJ Hicks
Radiographics 35 (2), 500-516, 2015
|Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer|
D Rischin, L Peters, R Hicks, P Hughes, R Fisher, R Hart, M Sexton, ...
Journal of Clinical Oncology 19 (2), 535-542, 2001
|The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification|
RJ Hicks, V Kalff, MP MacManus, RE Ware, AF McKenzie, JP Matthews, ...
Journal of Nuclear Medicine 42 (11), 1605-1613, 2001
|Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma|
A Wirth, JF Seymour, RJ Hicks, R Ware, R Fisher, M Prince, ...
The American journal of medicine 112 (4), 262-268, 2002
|Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.|
J vom Dahl, DT Eitzman, ZR Al-Aouar, HL Kanter, RJ Hicks, GM Deeb, ...
Circulation 90 (5), 2356-2366, 1994
|The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study|
V Kalff, RJ Hicks, RE Ware, A Hogg, D Binns, AF McKenzie
Journal of Nuclear Medicine 43 (4), 492-499, 2002